Amro Albanna - Aditxt Chairman CoFounder
| ADTX Stock | USD 2.43 0.24 8.99% |
Insider
Amro Albanna is Chairman CoFounder of Aditxt Inc
| Age | 54 |
| Address | 737 North Fifth Street, Richmond, VA, United States, 23219 |
| Phone | 650 870 1200 |
| Web | https://www.aditxt.com |
Amro Albanna Latest Insider Activity
Tracking and analyzing the buying and selling activities of Amro Albanna against Aditxt stock is an integral part of due diligence when investing in Aditxt. Amro Albanna insider activity provides valuable insight into whether Aditxt is net buyers or sellers over its current business cycle. Note, Aditxt insiders must abide by specific rules, including filing SEC forms every time they buy or sell Aditxt'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Amro Albanna over three months ago Acquisition by Amro Albanna of 9404 shares of Aditxt subject to Rule 16b-3 | ||
Amro Albanna over six months ago Purchase by Amro Albanna of 500 shares of Aditxt |
Aditxt Management Efficiency
The company has return on total asset (ROA) of (1.1753) % which means that it has lost $1.1753 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.986) %, meaning that it created substantial loss on money invested by shareholders. Aditxt's management efficiency ratios could be used to measure how well Aditxt manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.51 in 2024. Return On Capital Employed is likely to rise to -3.84 in 2024. At this time, Aditxt's Non Current Assets Total are fairly stable compared to the past year. Other Assets is likely to rise to about 587.7 K in 2024, whereas Total Assets are likely to drop slightly above 7.5 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| FACNP FACP | Plus Therapeutics | 74 | |
| Sharon McBrayer | Palisade Bio | N/A | |
| MD FAAAAI | Palisade Bio | N/A | |
| James Rolke | Revelation Biosciences | 55 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 55 | |
| MS MBA | Plus Therapeutics | N/A | |
| Tomasz George | Virax Biolabs Group | 40 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Gerald Proehl | Dermata Therapeutics | 65 | |
| Marc MD | Plus Therapeutics | 61 | |
| James Foster | Virax Biolabs Group | 39 | |
| Frank Kondrad | Neurobo Pharmaceuticals | N/A | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Stephen Sheldon | PaxMedica Common Stock | 44 | |
| David Hale | Dermata Therapeutics | 75 | |
| Gordon JD | Quoin Pharmaceuticals Ltd | 60 | |
| Jason Davis | Virax Biolabs Group | 52 | |
| Annie Rasmussen | Allarity Therapeutics | 67 | |
| Steen Knudsen | Allarity Therapeutics | 63 | |
| John Fraser | Plus Therapeutics | 63 | |
| Joan Brown | Allarity Therapeutics | 70 | |
Management Performance
| Return On Equity | -6.99 | ||||
| Return On Asset | -1.18 |
Aditxt Inc Leadership Team
Elected by the shareholders, the Aditxt's board of directors comprises two types of representatives: Aditxt inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aditxt. The board's role is to monitor Aditxt's management team and ensure that shareholders' interests are well served. Aditxt's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aditxt's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, President | ||
| Jennifer Lee, Director Resources | ||
| Thomas CPA, Chief Officer | ||
| Matthew Shatzkes, Chief Counsel | ||
| MS MD, Senior Discovery | ||
| Amro Albanna, Chairman CoFounder | ||
| Dolly Tyan, Senior Transplantation | ||
| Rowena Albanna, Chief Officer | ||
| DDS MS, Chief CoFounder |
Aditxt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aditxt a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.99 | ||||
| Return On Asset | -1.18 | ||||
| Operating Margin | (65.03) % | ||||
| Current Valuation | 6.13 M | ||||
| Shares Outstanding | 1.67 M | ||||
| Shares Owned By Insiders | 9.38 % | ||||
| Shares Owned By Institutions | 6.91 % | ||||
| Number Of Shares Shorted | 19.48 K | ||||
| Price To Book | 0.30 X | ||||
| Price To Sales | 6.69 X |
Pair Trading with Aditxt
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aditxt position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will appreciate offsetting losses from the drop in the long position's value.Moving against Aditxt Stock
| 0.69 | RZLT | Rezolute Trending | PairCorr |
| 0.67 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.65 | CELC | Celcuity LLC Financial Report 20th of May 2024 | PairCorr |
| 0.64 | MRK | Merck Company Report 25th of April 2024 | PairCorr |
| 0.61 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Aditxt could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aditxt when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aditxt - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aditxt Inc to buy it.
The correlation of Aditxt is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aditxt moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aditxt Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aditxt can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aditxt Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Aditxt Stock analysis
When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Aditxt's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aditxt. If investors know Aditxt will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aditxt listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.00) | Revenue Per Share 5.194 | Quarterly Revenue Growth (0.61) | Return On Assets (1.18) | Return On Equity (6.99) |
The market value of Aditxt Inc is measured differently than its book value, which is the value of Aditxt that is recorded on the company's balance sheet. Investors also form their own opinion of Aditxt's value that differs from its market value or its book value, called intrinsic value, which is Aditxt's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aditxt's market value can be influenced by many factors that don't directly affect Aditxt's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aditxt's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aditxt is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aditxt's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.